<?xml version="1.0" encoding="UTF-8"?>
<ClinicalDocument xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <realmCode code="US"/>
  <typeId root="2.16.840.1.113883.1.3" extension="POCD_HD000040"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.1" extension="2015-08-01"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.9" extension="2015-08-01"/>
  <id root="004dec21-31d7-460c-9202-c3835194b1aa"/>
  <code code="11506-3" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="Progress note"/>
  <title>SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Nelson Mandela — True-date frame: synthetic events are moved into the patient&apos;s historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.</title>
  <effectiveTime value="20010414120000-0500"/>
  <confidentialityCode code="N" codeSystem="2.16.840.1.113883.5.25"/>
  <languageCode code="en-US"/>
  <setId root="925d4a72-be17-449a-a385-d80138d13553"/>
  <versionNumber value="1"/>
  <recordTarget>
    <patientRole>
      <id root="61084987-1713-4db4-8572-02db649c0d0a" extension="HR-ML021-SYN-TD"/>
      <id root="2.16.840.1.113883.4.1" extension="000-21-6718"/>
      <addr nullFlavor="UNK"/>
      <telecom nullFlavor="UNK"/>
      <patient>
        <name use="L"><given>Nelson</given><family>Mandela</family></name>
        <administrativeGenderCode code="M" codeSystem="2.16.840.1.113883.5.1" displayName="Male"/>
        <birthTime value="19180718"/>
        <raceCode nullFlavor="ASKU"/>
        <ethnicGroupCode nullFlavor="ASKU"/>
        <languageCommunication><languageCode code="en"/><preferenceInd value="true"/></languageCommunication>
      </patient>
      <providerOrganization>
        <id root="6a7f851b-842b-45d7-9552-3e8582647414"/>
        <name>St. Posthumous Health Center</name>
      <telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr>
      </providerOrganization>
    </patientRole>
  </recordTarget>
  <author>
    <time value="20010414120000-0500"/>
    <assignedAuthor><id root="c4d853ba-3778-46ad-94f3-23f7de881159"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Thandiwe</given><family>Mokoena</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedAuthor>
  </author>
  <custodian>
    <assignedCustodian><representedCustodianOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedCustodianOrganization></assignedCustodian>
  </custodian>
  <legalAuthenticator>
    <time value="20010414120000-0500"/>
    <signatureCode code="S"/>
    <assignedEntity><id root="c4d853ba-3778-46ad-94f3-23f7de881159"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Thandiwe</given><family>Mokoena</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity>
  </legalAuthenticator>
  <documentationOf>
    <serviceEvent classCode="PCPR"><templateId root="2.16.840.1.113883.10.20.21.3.1"/><effectiveTime><low value="20010414"/><high value="20010414"/></effectiveTime><performer typeCode="PRF"><assignedEntity><id root="c4d853ba-3778-46ad-94f3-23f7de881159"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Thandiwe</given><family>Mokoena</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></performer></serviceEvent>
  </documentationOf>
  <componentOf>
    <encompassingEncounter>
      <id root="dbd1f8d0-3fc1-4659-a709-31cc3de0d146"/>
      <code code="390906007" codeSystem="2.16.840.1.113883.6.96" displayName="Follow-up encounter"><originalText>Five-week follow-up with radiation oncology consultation: staging result, shared decision on treatment, start of androgen deprivation, and bone density</originalText></code>
      <effectiveTime><low value="20010414"/><high value="20010414"/></effectiveTime>
      <encounterParticipant typeCode="ATND"><assignedEntity><id root="c4d853ba-3778-46ad-94f3-23f7de881159"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Thandiwe</given><family>Mokoena</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></encounterParticipant>
      <location><healthCareFacility><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><serviceProviderOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></serviceProviderOrganization></healthCareFacility></location>
    </encompassingEncounter>
  </componentOf>
  <component>
    <structuredBody>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.1.13.2.1"/>
    <code code="10154-3" codeSystem="2.16.840.1.113883.6.1" displayName="Chief complaint Narrative - Reported"/>
    <title>Chief Complaint</title>
    <text><paragraph>Five-week follow-up after the prostate cancer diagnosis; staging result; radiation oncology seen today. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.4"/>
    <code code="10164-2" codeSystem="2.16.840.1.113883.6.1" displayName="History of Present illness Narrative"/>
    <title>History of Present Illness</title>
    <text><paragraph>Mr. Mandela returns five weeks after his first visit. The PSMA PET/CT two weeks ago showed uptake only in the prostate, with no spread to lymph nodes or bone. He had his DXA scan this morning and then saw Dr. van Zyl of radiation oncology, who went through observation, radiotherapy with short-term androgen deprivation, and surgery with him. He chose radiotherapy to the prostate with six months of androgen deprivation. He starts bicalutamide today and will have his first leuprolide injection at the radiation oncology clinic in one week. Before starting, he was told the expected effects of androgen deprivation (hot flashes, tiredness, loss of libido and erections, weight gain, bone loss, and changes in mood or memory) and how they are monitored. His urinary symptoms are unchanged and mild. He has no bone pain, weight loss, or breathlessness. He starts vitamin D today for the low level found at the first visit. [S]</paragraph><table><thead><tr><th>Element</th><th>Detail</th></tr></thead><tbody><tr><td>Staging</td><td>PSMA PET/CT: disease confined to the prostate (N0 M0)</td></tr><tr><td>Decision</td><td>Radiotherapy with six months of androgen deprivation, after radiation oncology consultation today</td></tr><tr><td>Starting today</td><td>Bicalutamide 50 mg daily for four weeks; cholecalciferol 1000 units daily</td></tr><tr><td>Next step</td><td>First leuprolide injection in one week at radiation oncology</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.18"/>
    <code code="10187-3" codeSystem="2.16.840.1.113883.6.1" displayName="Review of systems Narrative - Reported"/>
    <title>Review of Systems</title>
    <text><table><thead><tr><th>System</th><th>Result</th><th>Finding</th></tr></thead><tbody><tr><td>Constitutional</td><td>Negative</td><td>No fatigue, weight loss, or night sweats</td></tr><tr><td>Genitourinary</td><td>Positive</td><td>Mild urinary frequency, unchanged; no blood in the urine</td></tr><tr><td>Musculoskeletal</td><td>Negative</td><td>No bone or back pain</td></tr><tr><td>Respiratory</td><td>Negative</td><td>No cough or breathlessness</td></tr><tr><td>Psychiatric</td><td>Negative</td><td>Mood good; PHQ-2 score 0</td></tr></tbody></table><paragraph>5 systems reviewed. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.1" extension="2014-06-09"/><templateId root="2.16.840.1.113883.10.20.22.2.1.1" extension="2014-06-09"/>
    <code code="10160-0" codeSystem="2.16.840.1.113883.6.1" displayName="History of Medication use Narrative"/>
    <title>Medications</title>
    <text><table><thead><tr><th>Medication</th><th>Frequency</th><th>Route</th><th>Dates</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="medication-1"><td>Bicalutamide 50 mg oral tablet, one tablet by mouth once daily for four weeks, to block the testosterone flare at the start of leuprolide</td><td>One tablet once daily for four weeks</td><td>Oral route</td><td>2001-04-14 to 2001-05-12</td><td>completed</td><td>S</td></tr><tr ID="medication-3"><td>Cholecalciferol (vitamin D3) 1000 units oral tablet, one tablet by mouth once daily</td><td>One tablet once daily</td><td>Oral route</td><td>2001-04-14</td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="aa70f948-acf2-436c-9d1d-08e765ced7b7"/>
      <text><reference value="#medication-1"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20010414"/><high value="20010512"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="199123" codeSystem="2.16.840.1.113883.6.88" displayName="bicalutamide 50 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="99b85595-50de-460f-93d3-a3a5a2c50938"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="C61" codeSystem="2.16.840.1.113883.6.90" displayName="Malignant neoplasm of prostate"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="7834d13a-3bea-4942-8ccb-88ab05621c4f"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="Z79.899" codeSystem="2.16.840.1.113883.6.90" displayName="Other long term (current) drug therapy"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="a32c69cf-9012-43ec-8754-abf2c838f9c0"/>
      <text><reference value="#medication-3"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20010414"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="199362" codeSystem="2.16.840.1.113883.6.88" displayName="cholecalciferol 0.025 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="3510a053-f557-4cb5-b4fc-7cab2aaff619"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="Z79.899" codeSystem="2.16.840.1.113883.6.90" displayName="Other long term (current) drug therapy"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.6" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.6.1" extension="2015-08-01"/>
    <code code="48765-2" codeSystem="2.16.840.1.113883.6.1" displayName="Allergies and adverse reactions Document"/>
    <title>Allergies and Intolerances</title>
    <text><table><thead><tr><th>Allergy</th><th>Reaction</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="allergy-1"><td>No known allergy</td><td></td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.30" extension="2015-08-01"/>
      <id root="f0634d68-84e9-40bb-b629-e60695addf8f"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20010310"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN" negationInd="true">
          <templateId root="2.16.840.1.113883.10.20.22.4.7" extension="2014-06-09"/>
          <id root="68624d75-85d9-4b35-b1d6-e417b7d1d465"/>
          <code code="ASSERTION" codeSystem="2.16.840.1.113883.5.4"/>
          <text><reference value="#allergy-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low nullFlavor="UNK"/></effectiveTime>
          <value xsi:type="CD" code="419199007" codeSystem="2.16.840.1.113883.6.96" displayName="Allergy to substance"/>
          <participant typeCode="CSM"><participantRole classCode="MANU"><playingEntity classCode="MMAT"><code nullFlavor="NA"/></playingEntity></participantRole></participant>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.4" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.4.1" extension="2015-08-01"/>
    <code code="8716-3" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs"/>
    <title>Vital Signs</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="vital-2-1"><td>2001-04-14</td><td>Body height</td><td>183</td><td>cm</td><td>S</td></tr>
  <tr ID="vital-2-2"><td>2001-04-14</td><td>Body weight</td><td>80.4</td><td>kg</td><td>S</td></tr>
  <tr ID="vital-2-3"><td>2001-04-14</td><td>Body mass index (BMI) [Ratio]</td><td>24</td><td>kg/m2</td><td>S</td></tr>
  <tr ID="vital-2-4"><td>2001-04-14</td><td>Systolic blood pressure</td><td>130</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-2-5"><td>2001-04-14</td><td>Diastolic blood pressure</td><td>76</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-2-6"><td>2001-04-14</td><td>Heart rate</td><td>66</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-2-7"><td>2001-04-14</td><td>Respiratory rate</td><td>14</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-2-8"><td>2001-04-14</td><td>Body temperature</td><td>36.7</td><td>Cel</td><td>S</td></tr>
  <tr ID="vital-2-9"><td>2001-04-14</td><td>Oxygen saturation in Arterial blood by Pulse oximetry</td><td>97</td><td>%</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.26" extension="2015-08-01"/>
      <id root="73076ae7-ac80-4bbd-9bd5-ed453c494067"/>
      <code code="74728-7" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs, weight, height, head circumference, oximetry, BMI, and BSA panel - HL7.FHIR.R4"/>
      <statusCode code="completed"/><effectiveTime value="20010414"/>
      <component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="08e4e1e0-d10d-4de2-a066-afdaaf342620"/><code code="8302-2" codeSystem="2.16.840.1.113883.6.1" displayName="Body height"/><text><reference value="#vital-2-1"/></text><statusCode code="completed"/><effectiveTime value="20010414"/><value xsi:type="PQ" value="183" unit="cm"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="c161a8ea-5932-4c9a-aad2-b729937cf095"/><code code="29463-7" codeSystem="2.16.840.1.113883.6.1" displayName="Body weight"/><text><reference value="#vital-2-2"/></text><statusCode code="completed"/><effectiveTime value="20010414"/><value xsi:type="PQ" value="80.4" unit="kg"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="f8d6465d-6b44-49d9-9e5c-452f8facbd88"/><code code="39156-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body mass index (BMI) [Ratio]"/><text><reference value="#vital-2-3"/></text><statusCode code="completed"/><effectiveTime value="20010414"/><value xsi:type="PQ" value="24" unit="kg/m2"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="85b413da-0bbe-4e55-966c-590b950831b8"/><code code="8480-6" codeSystem="2.16.840.1.113883.6.1" displayName="Systolic blood pressure"/><text><reference value="#vital-2-4"/></text><statusCode code="completed"/><effectiveTime value="20010414"/><value xsi:type="PQ" value="130" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="a2eb453a-b3be-45d4-8d15-497437b811d1"/><code code="8462-4" codeSystem="2.16.840.1.113883.6.1" displayName="Diastolic blood pressure"/><text><reference value="#vital-2-5"/></text><statusCode code="completed"/><effectiveTime value="20010414"/><value xsi:type="PQ" value="76" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="b82f0e32-d4aa-4160-929a-14c67994ef9c"/><code code="8867-4" codeSystem="2.16.840.1.113883.6.1" displayName="Heart rate"/><text><reference value="#vital-2-6"/></text><statusCode code="completed"/><effectiveTime value="20010414"/><value xsi:type="PQ" value="66" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="e29dba1e-b8a8-426c-9588-526a040f36f1"/><code code="9279-1" codeSystem="2.16.840.1.113883.6.1" displayName="Respiratory rate"/><text><reference value="#vital-2-7"/></text><statusCode code="completed"/><effectiveTime value="20010414"/><value xsi:type="PQ" value="14" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="ed0ccd23-44ae-4f95-a220-931ab44db95e"/><code code="8310-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body temperature"/><text><reference value="#vital-2-8"/></text><statusCode code="completed"/><effectiveTime value="20010414"/><value xsi:type="PQ" value="36.7" unit="Cel"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="1f74e413-b6fb-4e35-a405-a7047c39eff0"/><code code="59408-5" codeSystem="2.16.840.1.113883.6.1" displayName="Oxygen saturation in Arterial blood by Pulse oximetry"/><text><reference value="#vital-2-9"/></text><statusCode code="completed"/><effectiveTime value="20010414"/><value xsi:type="PQ" value="97" unit="%"/></observation></component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.3" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.3.1" extension="2015-08-01"/>
    <code code="30954-2" codeSystem="2.16.840.1.113883.6.1" displayName="Relevant Diagnostic Tests and/or Laboratory Data"/>
    <title>Results</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Reference range</th><th>Flag</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="result-23"><td>2001-04-14</td><td>DXA Femur [T-score] Bone density</td><td>-1.4</td><td>{T-score}</td><td>-1.0 or higher is normal; -2.5 or lower is osteoporosis</td><td>Low</td><td>S</td></tr>
  <tr ID="result-24"><td>2001-04-14</td><td>DXA Lumbar spine [T-score] Bone density</td><td>-0.6</td><td>{T-score}</td><td>-1.0 or higher is normal; -2.5 or lower is osteoporosis</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-25"><td>2001-04-14</td><td>Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]</td><td>0</td><td>{score}</td><td></td><td></td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="06b1147a-1e82-4f6c-acfc-7c3f723ac96b"/>
      <code code="38263-0" codeSystem="2.16.840.1.113883.6.1" displayName="DXA Femur [T-score] Bone density"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20010414"/><high value="20010414"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="7a52142e-94ff-4328-bc7a-975d7688f839"/>
          <code code="38263-0" codeSystem="2.16.840.1.113883.6.1" displayName="DXA Femur [T-score] Bone density"/>
          <text><reference value="#result-23"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20010414"/>
          <value xsi:type="PQ" value="-1.4" unit="{T-score}"/>
          <interpretationCode code="L" codeSystem="2.16.840.1.113883.5.83" displayName="Low"/>
          <referenceRange>
            <observationRange>
              <text>-1.0 or higher is normal; -2.5 or lower is osteoporosis</text>
              <value xsi:type="IVL_PQ"><low value="-1" unit="{T-score}"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="96448c5b-01fd-4ad1-85bb-3f1939978be2"/>
      <code code="38267-1" codeSystem="2.16.840.1.113883.6.1" displayName="DXA Lumbar spine [T-score] Bone density"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20010414"/><high value="20010414"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="7d5745e0-1608-4ada-a841-32e1dec08748"/>
          <code code="38267-1" codeSystem="2.16.840.1.113883.6.1" displayName="DXA Lumbar spine [T-score] Bone density"/>
          <text><reference value="#result-24"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20010414"/>
          <value xsi:type="PQ" value="-0.6" unit="{T-score}"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>-1.0 or higher is normal; -2.5 or lower is osteoporosis</text>
              <value xsi:type="IVL_PQ"><low value="-1" unit="{T-score}"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="5df2c33f-593a-4bd5-9a0d-85781efc970f"/>
      <code code="55758-7" codeSystem="2.16.840.1.113883.6.1" displayName="Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20010414"/><high value="20010414"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="4e261b52-b57d-4193-a62f-07c19dcf7d6f"/>
          <code code="55758-7" codeSystem="2.16.840.1.113883.6.1" displayName="Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]"/>
          <text><reference value="#result-25"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20010414"/>
          <value xsi:type="PQ" value="0" unit="{score}"/>
        </observation>
      </component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.2.10" extension="2015-08-01"/>
    <code code="29545-1" codeSystem="2.16.840.1.113883.6.1" displayName="Physical findings note"/>
    <title>Physical Exam</title>
    <text><paragraph>Vital signs recorded on 2001-04-14; see the Vital Signs section. [S]</paragraph><table><thead><tr><th>System</th><th>Finding</th></tr></thead><tbody><tr><td>General</td><td>Well</td></tr><tr><td>Cardiovascular</td><td>Regular rhythm; blood pressure 130/76 mm Hg; no ankle swelling</td></tr><tr><td>Abdomen</td><td>Soft; bladder not palpable</td></tr><tr><td>Musculoskeletal</td><td>No spinal tenderness</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.5" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.5.1" extension="2015-08-01"/>
    <code code="11450-4" codeSystem="2.16.840.1.113883.6.1" displayName="Problem List"/>
    <title>Problems</title>
    <text><table><thead><tr><th>Problem</th><th>Clinical status</th><th>Verification</th><th>Code</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="problem-1">
    <td>Adenocarcinoma of the prostate, NCCN unfavorable intermediate risk: cT1c, Grade Group 3 (Gleason 4+3), PSA 6.4 ng/mL, 3 of 14 cores, found after a rising PSA; synthetic modern detail linked to his publicly announced prostate cancer</td><td>active</td><td>confirmed</td>
    <td>C61</td><td>S — Synthetic grade, PSA, core count, stage, and risk group; the PSA rise, the biopsy-proven localized cancer that was not high grade, hormone therapy, and curative radiotherapy are from his doctors&apos; and spokeswoman&apos;s public statements (D).</td>
  </tr>
  <tr ID="problem-2">
    <td>Hormone-sensitive prostate cancer</td><td>active</td><td>confirmed</td>
    <td>Z19.1</td><td>S — Synthetic status in the modern episode.</td>
  </tr>
  <tr ID="problem-3">
    <td>Short-term androgen deprivation therapy (six months, leuprolide), with monitoring of testosterone, bone density, metabolic and cardiovascular risk, hot flashes, mood, and cognition</td><td>active</td><td>confirmed</td>
    <td>Z79.899</td><td>S — Synthetic androgen deprivation plan; Z79.899 is used because ICD-10-CM has no specific code for GnRH agonist therapy.</td>
  </tr>
  <tr ID="problem-4">
    <td>History of pulmonary tuberculosis, treated, with no symptoms since</td><td>resolved</td><td>confirmed</td>
    <td>Z86.11</td><td>S — The 1988 tuberculosis is documented (D); the coding and the statement that it has not recurred are synthetic.</td>
  </tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="f580d6cf-d9bf-4ea0-9f06-be088ebe8019"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20010310"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="c28d8e54-f1f1-4292-9bd9-22432c39281e"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20010310"/></effectiveTime>
          <value xsi:type="CD" code="C61" codeSystem="2.16.840.1.113883.6.90" displayName="Malignant neoplasm of prostate"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="16adb80a-2696-4a7f-8605-05bd7fb89e5f"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20010310"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="dfac41d8-4a7a-4929-9332-96e8e31aa8c7"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-2"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20010310"/></effectiveTime>
          <value xsi:type="CD" code="Z19.1" codeSystem="2.16.840.1.113883.6.90" displayName="Hormone sensitive malignancy status"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="37d0b777-e4df-428c-b79f-d7c2a24d1607"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20010414"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="36b380fb-124d-45b9-ac43-f4aa8fb2c60c"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-3"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20010414"/></effectiveTime>
          <value xsi:type="CD" code="Z79.899" codeSystem="2.16.840.1.113883.6.90" displayName="Other long term (current) drug therapy"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="b24d7f5d-69a5-4773-b8e7-f6116dd7a6ca"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20010310"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="e5fe3391-dc62-4108-a6f2-0d29ebe3b68a"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-4"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20010310"/></effectiveTime>
          <value xsi:type="CD" code="Z86.11" codeSystem="2.16.840.1.113883.6.90" displayName="Personal history of tuberculosis"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.9" extension="2014-06-09"/>
    <code code="51847-2" codeSystem="2.16.840.1.113883.6.1" displayName="Evaluation + Plan note"/>
    <title>Assessment and Plan</title>
    <text><list listType="ordered"><item><content styleCode="Bold">Prostate cancer, unfavorable intermediate risk, cT1c N0 M0 (C61)</content>. Staging is complete and shows localized disease. The decision for radiotherapy with six months of androgen deprivation follows the radiation oncology consultation and the guidelines for unfavorable intermediate risk in a fit man of his age. [S]<list><item>Bicalutamide 50 mg daily for four weeks from today.</item><item>Leuprolide 22.5 mg in one week, then every twelve weeks for a second dose.</item><item>Fiducial markers and planning scans in about twelve weeks; radiotherapy to start about three months after leuprolide.</item></list></item><item><content styleCode="Bold">Androgen deprivation therapy: baseline (Z79.899)</content>. Baseline testosterone 412 ng/dL, hemoglobin A1c 5.5 percent, LDL 112 mg/dL, and blood pressure 130/76 mm Hg. DXA shows low bone mass at the femoral neck (T-score -1.4) with a normal spine (-0.6). His ten-year hip fracture risk is below the 3 percent treatment threshold, so no bone drug is needed now. Vitamin D was 26 ng/mL. [S]<list><item>Cholecalciferol 1000 units daily from today.</item><item>Calcium from food, about 1000 to 1200 mg a day; walking and resistance exercise.</item><item>PSA, testosterone, and vitamin D in three months; DXA again in one to two years.</item></list></item></list><paragraph>Protocol monitoring: items the monitoring protocol calls for at this visit. [S]</paragraph><table><thead><tr><th>Domain</th><th>Measure</th><th>Interval</th><th>Status</th><th>Detail</th></tr></thead><tbody><tr><td>Laboratory</td><td>PSA before treatment</td><td>At diagnosis, then every 3 to 6 months on androgen deprivation</td><td>Up to date</td><td>6.4 ng/mL at the first visit; next on androgen deprivation in three months</td></tr><tr><td>Laboratory</td><td>Testosterone</td><td>Baseline, then every 3 to 6 months on androgen deprivation (target below 50 ng/dL)</td><td>Up to date</td><td>412 ng/dL at the first visit, before treatment; recheck in three months</td></tr><tr><td>Laboratory</td><td>Hemoglobin A1c or fasting glucose, and lipid panel</td><td>Baseline and yearly on androgen deprivation</td><td>Up to date</td><td>A1c 5.5 percent, glucose 94 mg/dL, LDL 112 mg/dL at the first visit; next in one year</td></tr><tr><td>Laboratory</td><td>Calcium and 25-hydroxyvitamin D</td><td>Baseline and periodically on androgen deprivation</td><td>Due</td><td>Calcium 9.4 mg/dL and vitamin D 26 ng/mL at the first visit; supplement starts today; vitamin D recheck in three months</td></tr><tr><td>Imaging</td><td>Bone density (DXA)</td><td>Baseline before androgen deprivation, then every 1 to 2 years</td><td>Completed today</td><td>Femoral neck T-score -1.4 (low bone mass); lumbar spine -0.6 (normal); hip fracture risk below the treatment threshold</td></tr><tr><td>Imaging</td><td>PSMA PET/CT staging</td><td>Once, for unfavorable intermediate or high risk</td><td>Up to date</td><td>Two weeks ago: no nodal, bone, or visceral disease</td></tr><tr><td>Examination</td><td>Blood pressure and cardiovascular assessment</td><td>Every visit on androgen deprivation</td><td>Completed today</td><td>130/76 mm Hg; no chest pain or breathlessness; baseline before treatment</td></tr><tr><td>Survey</td><td>Distress and depression screen (PHQ-2)</td><td>At diagnosis and at intervals</td><td>Completed today</td><td>PHQ-2 score 0</td></tr><tr><td>Survey</td><td>Urinary symptoms (IPSS)</td><td>Baseline before treatment, then every follow-up visit</td><td>Up to date</td><td>IPSS 7 (mild) at the first visit; no change today</td></tr><tr><td>Survey</td><td>Sexual function</td><td>Baseline before treatment and periodically</td><td>Completed today</td><td>Reviewed before androgen deprivation; the expected effects were explained</td></tr><tr><td>Survey</td><td>Cognition</td><td>Periodically on androgen deprivation</td><td>Due</td><td>Cognitive screen at the annual wellness visit in about eight weeks</td></tr><tr><td>Medication safety</td><td>Hot flashes and fatigue</td><td>Every visit on androgen deprivation</td><td>Not indicated</td><td>Androgen deprivation not yet started; counseled on what to expect</td></tr><tr><td>Medication safety</td><td>Testosterone flare protection</td><td>When starting a GnRH agonist</td><td>Completed today</td><td>Bicalutamide starts today, one week before leuprolide, and continues for four weeks</td></tr><tr><td>Referral</td><td>Radiation oncology</td><td>Once, then through treatment</td><td>Completed today</td><td>Seen today; recommendations in the consultation note</td></tr><tr><td>Self-management</td><td>Physical activity, calcium intake, and no tobacco</td><td>Every visit</td><td>Completed today</td><td>Walking every morning; resistance exercise added; dietary calcium reviewed</td></tr></tbody></table><paragraph>Goal progress:</paragraph><list><item>Reach an informed, shared decision on treatment after hearing every reasonable option, including observation. Outcome by 2001-04-14: Radiotherapy with six months of androgen deprivation chosen at the radiation oncology consultation [S]</item><item>Complete six months of androgen deprivation and the course of radiotherapy with side effects managed. In progress; target 2001-10-27 [S]</item><item>Protect bone health on androgen deprivation: baseline DXA, vitamin D of 30 ng/mL or more, dietary calcium, and weight-bearing exercise. In progress; target 2001-07-14 [S]</item><item>PSA falling after radiotherapy, with a written surveillance plan. In progress; target 2001-10-27 [S]</item></list><paragraph>Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer (2026); Eastham JA, et al. Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management. J Urol 2022;208(1):10-18 (2022); Skolarus TA, et al. American Cancer Society prostate cancer survivorship care guidelines. CA Cancer J Clin 2014;64(4):225-249 (2014); CMID: Clinical Monitoring Intelligence Database, prostate cancer monograph (2026)</paragraph><paragraph>Follow-up: Leuprolide at radiation oncology in one week. Annual wellness visit in eight weeks. Primary care follow-up in three months with PSA, testosterone, and vitamin D. Next scheduled visit 2001-06-09: subsequent annual wellness visit. [S]</paragraph></text>

  </section>
</component>
    </structuredBody>
  </component>
</ClinicalDocument>
